Bio-logic Systems Corp. is selling 14 acres of vacant land next to its Mundelein headquarters for a sum worth 10% of last year's revenues, the company said Monday in a regulatory filing. Buying the ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--Jan. 5, 2006--Natus Medical Incorporated (Nasdaq:BABY) announced that it has completed today its acquisition of Bio-logic Systems Corp. Bio-logic formerly traded ...
$8M grant supports ongoing Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia SOUTH SAN FRANCISCO, Calif., July 01, ...
The positive preliminary SENTI-202 clinical data was presented on April 27 in a Clinical Trials Oral Minisymposium at the American Association for Cancer Research (AACR) Annual Meeting 2025 in an ...
Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating ...
AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced ...
Researchers at Rice University and the University of Kansas Medical Center are making genetic circuits that can perform more complex tasks by swapping protein building blocks. The modular genetic ...
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results